REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
批准号:
3779503
负责人:
J MOSS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Toxins appear to be responsible in part for the clinical presentation of
some diseases due to bacterial infection. Pertussis toxin, a secretory
product of Bordetella pertussis involved in the pathogenesis of whooping
cough, and cholera toxin (CT), an etiologic agent in cholera toxin, exert
their effect on cells through the ADP-ribosylation of guanine nucleotide-
binding (G) proteins that are critical for signaling from cell surface
receptors to their intracellular targets (e.g., adenylyl cyclase).
Cholera toxin consists of one A subunit, which is an ADP-
ribosyltransferase, and five B subunits which bind the toxin to its cell
surface receptor, ganglioside GM1. A substrate for the A subunit in
disease appears to be the alpha subunit of Gs, the stimulatory G protein
of the adenylyl cyclase system and a G protein that may regulate ion
flux. Cholera toxin also catalyzes the ADP-ribosylation of simple
guanidino compounds (e.g., agmatine, arginine), proteins unrelated to
Gsalpha, presumably due to the presence of an accessible arginine
residue, and its own A subunit in an auto-ADP-ribosylation reaction. All
toxin-catalyzed reactions are enhanced by ARF, consistent with its
proposed role as an allosteric activator of CTA1. The present study was
undertaken to determine, using in vitro mutagenesis, amino acid residues
that may participate in recognition of the G protein by cholera toxin.
The assumption was made that recognition of Gsalpha should require the
participation of more of the protein structure than would ADP-
ribosylation of a simple guanidino compound such as agmatine. Based on
this model it was hypothesized that mutations of CTA1 might exist which
would preferentially affect ADP-ribosylation of Gs rather than ADP-
ribosylation of agmatine. Based on structural analogies between cholera
toxin and other bacterial toxins such as pertussis toxin, a number of
CTA1 mutations were synthesized in E. coli. Mutations were examined for
their ability to ADP-ribosylate agmatine, Gsalpha, and transducin (or
Gtalpha) as well as to auto-ADP-ribosylate in various
phospholipid/detergent mixtures. Several mutations (e.g., at positions
7, 44, and 112) resulted in overall loss of enzymatic activity.
Substitution of asparagine for histidine-70, however, diminished ADP-
ribosyl-Gsalpha formation more than it did ADP-ribosylagmatine synthesis.
These and other data suggest that histidine-70 may be involved in
specific recognition of Gsalpha by cholera toxin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF MAMMALIAN ADP-RIBOSLYTRANSFERASES
-
批准号:2576748
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
CHARACTERIZATION OF THE PATHOGENESIS OF LYMPHANGIOLEIOMYOMATOSIS (LAM)
-
批准号:2441409
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3857979
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
ROLE OF NITRIC OXIDE IN THE PATHOGENESIS OF LUNG DISEASE
-
批准号:2576802
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
ADP-RIBOSYLATION CYCLES
-
批准号:6162671
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
MOLECULAR CHARACTERISTICS AND CLINICAL ASPECTS OF ALPHA 1-ANTITRYPSIN DEFICIENCY
-
批准号:6162714
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
MOLECULAR CHARACTERISTICS AND CLINICAL ASPECTS OF ALPHA 1-ANTITRYPSIN DEFICIENCY
-
批准号:2576803
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
ROLE OF NITRIC OXIDE IN THE PATHOGENESIS OF LUNG DISEASE
-
批准号:6162713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
CHARACTERIZATION OF MAMMALIAN ADP-RIBOSLYTRANSFERASES
-
批准号:6162666
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
PATHOGENESIS AND THERAPY OF PULMONARY FIBROSIS
-
批准号:6109234
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
ADP-RIBOSYLATION CYCLES
-
批准号:2576753
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3843260
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
MOLECULAR CHARACTERISTICS AND CLINICAL ASPECTS OF ALPHA 1-ANTITRYPSIN DEFICIENCY
-
批准号:6109231
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE MECHANISMS
-
批准号:4694491
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
TRANSDUCIN GTPASE--GENES FOR GTP-BINDING PROTEINS
-
批准号:4694497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3878894
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3919996
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
CHARACTERIZATION OF THE PATHOGENESIS OF LYMPHANGIOLEIOMYOMATOSIS (LAM)
-
批准号:6162716
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3942780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3966535
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: